Difference between revisions of "Brendon J. Coventry"
(→Journal articles) |
|||
| Line 4: | Line 4: | ||
[http://www.eleceng.adelaide.edu.au/personal/dabbott/publications/FTR_ashdown2015.pdf] | [http://www.eleceng.adelaide.edu.au/personal/dabbott/publications/FTR_ashdown2015.pdf] | ||
[[Martin L. Ashdown|M. L. Ashdown]], [[Andrew P. Robinson|A. P. Robinson]], [[Steven L. Yatomi-Clarke|S. L. Yatomi-Clarke]], [[M. Luisa Ashdown|M. L. Ashdown]], [[Andrew G. Allison|A. Allison]], '''[[Derek Abbott|D. Abbott]]''', [[Svetomir N. Markovic|S. N. Markovic]], and [[Brendon J. Coventry|B. J. Coventry]], "Chemotherapy for late-stage cancer patients: Meta-analysis of complete response rates," ''F1000Research,'' '''Vol. 4,''' Art. No. 232, 2015, http://dx.doi.org/10.12688/f1000research.6760.1 [https://scholar.google.com.au/citations?view_op=view_citation&hl=en&user=vqD_0uQAAAAJ&sortby=pubdate&citation_for_view=vqD_0uQAAAAJ:5N-NJrZHaHcC Scholar Google hits] [https://www.researchgate.net/publication/281806627 ResearchGate] [https://www.academia.edu/19192313 Academia] | [[Martin L. Ashdown|M. L. Ashdown]], [[Andrew P. Robinson|A. P. Robinson]], [[Steven L. Yatomi-Clarke|S. L. Yatomi-Clarke]], [[M. Luisa Ashdown|M. L. Ashdown]], [[Andrew G. Allison|A. Allison]], '''[[Derek Abbott|D. Abbott]]''', [[Svetomir N. Markovic|S. N. Markovic]], and [[Brendon J. Coventry|B. J. Coventry]], "Chemotherapy for late-stage cancer patients: Meta-analysis of complete response rates," ''F1000Research,'' '''Vol. 4,''' Art. No. 232, 2015, http://dx.doi.org/10.12688/f1000research.6760.1 [https://scholar.google.com.au/citations?view_op=view_citation&hl=en&user=vqD_0uQAAAAJ&sortby=pubdate&citation_for_view=vqD_0uQAAAAJ:5N-NJrZHaHcC Scholar Google hits] [https://www.researchgate.net/publication/281806627 ResearchGate] [https://www.academia.edu/19192313 Academia] | ||
| + | |||
| + | [http://www.eleceng.adelaide.edu.au/personal/dabbott/publications/JIC_ashdown2013.pdf] | ||
| + | [[Martin L. Ashdown|M. L. Ashdown]], [[Brendon J. Coventry|B. J. Coventry]], and '''[[Derek Abbott|D. Abbott]]''', "Mathematical modeling of immune kinetics | ||
| + | in advanced cancer through meta-analyses of complete response rates: immune synchronisation emerges as the likely key determinant of clinical response," ''Journal for ImmunoTherapy of Cancer'', '''Vol. 1'''(Suppl 1), p. 150, 2013, http://dx.doi.org/10.1186/2051-1426-1-S1-P150 [http://scholar.google.com.au/citations?view_op=view_citation&hl=en&user=vqD_0uQAAAAJ&cstart=20&sortby=pubdate&citation_for_view=vqD_0uQAAAAJ:P2d6BWbXU0IC Scholar Google hits] [https://www.researchgate.net/publication/265382919 ResearchGate] | ||
Latest revision as of 14:40, 24 May 2017
Coventry's Google Scholar profile
Journal articles
[1] M. L. Ashdown, A. P. Robinson, S. L. Yatomi-Clarke, M. L. Ashdown, A. Allison, D. Abbott, S. N. Markovic, and B. J. Coventry, "Chemotherapy for late-stage cancer patients: Meta-analysis of complete response rates," F1000Research, Vol. 4, Art. No. 232, 2015, http://dx.doi.org/10.12688/f1000research.6760.1 Scholar Google hits ResearchGate Academia
[2] M. L. Ashdown, B. J. Coventry, and D. Abbott, "Mathematical modeling of immune kinetics in advanced cancer through meta-analyses of complete response rates: immune synchronisation emerges as the likely key determinant of clinical response," Journal for ImmunoTherapy of Cancer, Vol. 1(Suppl 1), p. 150, 2013, http://dx.doi.org/10.1186/2051-1426-1-S1-P150 Scholar Google hits ResearchGate
